N/A
Completed N=8
A Mobile Tai Chi Platform for Fall Prevention and Cognition in Older Adults
Aging · Fall
Source: ClinicalTrials.gov NCT05209464 ↗
Enrolled (actual)
8
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcomePrimary: Protocol Adherence — 78.6 percentage of sessions completed
Summary
The investigators will assess feasibility and acceptability of the Tele-Tai Chi (TC) intervention; explore changes in clinically relevant outcome measures including: physical activity, self-efficacy, quality of life, cognitive function, balance, gait, and evaluate changes in TC proficiency. To achieve this, the investigators are running a single-arm study for older adults that involves a 12-week home-based Tai Chi intervention. Study participation includes four remote and/or in-person (at Spaulding Rehabilitation Hospital) visits to evaluate study participants (mobility tests and questionnaires).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Protocol Adherence |
78.6 | — |
| PRIMARY Retention of Study Participants |
87.5 | — |
| PRIMARY System Usability Scale |
87.9 | — |
Eligibility Criteria
Inclusion Criteria
- Men and women between 60 and 85 years old
- Naïve to Tai-Chi practice (never practiced TC)
- Montreal Cognitive Assessment (MoCA) score between 17 and 13.
- Self-reported ability to walk continuously for 15 minutes without an assistive device
- Working email address
- Prior experience with and current access to a computer, smart phone or tablet device
Exclusion Criteria
- Chronic neuromuscular conditions (e.g. Parkinson's disease, multiple sclerosis, stroke)
- Acute medical conditions requiring hospitalization within the past 6 months or that could interfere with safely participating in the study
- Active cancer
- Significant musculoskeletal conditions requiring chronic use of pain medication
- Significant cognitive impairment (Diagnosed with dementia (self-reported), or Montreal Cognitive Assessment (MoCA)-Blind score < 13)
Data sourced from ClinicalTrials.gov (NCT05209464). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.